Literature DB >> 22514381

Transient in vivo selection of a constitutively cephalosporin resistant Enterobacter cloacae causing ventriculitis.

A Joffe1, A Kabani, K Ramotar, W Krulicki, G Cadrain, T Jadavji.   

Abstract

A case of neonatal ventriculitis complicating a ventriculoperitoneal shunt and caused by one strain of Enterobacter cloacae (as shown on pulsed field gel electrophoresis) is presented. Daily ventricular fluid cultures from day 1 to 9 revealed inducible cephalosporin resistance in all isolates except on days 3, 4 and 5 of therapy when isolates were constitutively resistant. This emergence of resistance due to constitutive Bush class 1 beta-lactamase production is an excellent example of the rapid emergence of a predominant strain of bacteria depending on antibiotic selection pressures in vivo. The transient nature of the predominant resistant phenotype may have been due to missing a dose of cefotaxime on day 5 or in vivo factors allowing persistence of sensitive organisms in antibiotic protected sites. Caution is advised in the use of cephalosporins alone for serious Enterobacter species infections. Repeat culture and sensitivity should be done in severe infections that are slow to respond to cephalosporin therapy.

Entities:  

Keywords:  Constitutive resistance; Enterobacter cloacae

Year:  1995        PMID: 22514381      PMCID: PMC3327900          DOI: 10.1155/1995/539351

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  21 in total

1.  An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre.

Authors:  S S Pedersen; C Koch; N Høiby; K Rosendal
Journal:  J Antimicrob Chemother       Date:  1986-04       Impact factor: 5.790

Review 2.  Inducible beta-lactamases: clinical and epidemiologic implications for use of newer cephalosporins.

Authors:  W E Sanders; C C Sanders
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

3.  Accuracy of microdilution and the AutoMicrobic System in detection of beta-lactam resistance in gram-negative bacterial mutants with derepressed beta-lactamase.

Authors:  J A Washington; C C Knapp; C C Sanders
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

4.  Clinical consequences of development of resistance to third generation cephalosporins.

Authors:  F Follath; E Costa; A Thommen; R Frei; A Burdeska; J Meyer
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

Review 5.  Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods.

Authors:  D M Livermore
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

6.  How predictable is development of resistance after beta-lactam therapy in Enterobacter cloacae infection?

Authors:  M Michéa-Hamzehpour; J C Pechère
Journal:  J Antimicrob Chemother       Date:  1989-09       Impact factor: 5.790

7.  Major trends in the microbial etiology of nosocomial infection.

Authors:  D R Schaberg; D H Culver; R P Gaynes
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

8.  Development of beta-lactam-resistant Enterobacter cloacae in mice.

Authors:  B Marchou; M Michea-Hamzehpour; C Lucain; J C Pechère
Journal:  J Infect Dis       Date:  1987-08       Impact factor: 5.226

9.  Epidemiological fingerprinting of Enterobacter cloacae by small-fragment restriction endonuclease analysis and pulsed-field gel electrophoresis of genomic restriction fragments.

Authors:  R Haertl; G Bandlow
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

10.  Cefotaxime therapy of neonatal gram-negative bacillary meningitis.

Authors:  S H Naqvi; M A Maxwell; L M Dunkle
Journal:  Pediatr Infect Dis       Date:  1985 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.